Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 28, 2017
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Award
Stock Options
2017-06-26+20,000→ 20,000 totalExercise: $3.70Exp: 2027-06-26→ Common Stock (20,000 underlying)
Holdings
- 292,783
Common Stock
- 375,000
Stock Options
Exercise: $3.64Exp: 2026-02-28→ Common Stock (375,000 underlying)
Footnotes (2)
- [F1]Subject to Mr. Cartt's continued service on the Board of the Company, the stock options over four equal quarterly installments beginning on July 1, 2017. The stock options are exercisable upon vesting.
- [F2]Of such stock options, 62,500 have not vested as of the date hereof.